The association of polymorphic N-acetyltransferase (NAT2) with breast cancer risk. 1995

C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
Department of Social and Preventive Medicine, State University of New York at Buffalo 14214, USA.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001191 Arylamine N-Acetyltransferase An enzyme that catalyzes the transfer of acetyl groups from ACETYL-COA to arylamines. It can also catalyze acetyl transfer between arylamines without COENZYME A and has a wide specificity for aromatic amines, including SEROTONIN. However, arylamine N-acetyltransferase should not be confused with the enzyme ARYLALKYLAMINE N-ACETYLTRANSFERASE which is also referred to as SEROTONIN ACETYLTRANSFERASE. Arylamine Acetylases,Arylamine Acetyltransferases,Acetyl-CoA Arylamine N-Acetyltransferase,Arylamine Acetylase,Acetyl CoA Arylamine N Acetyltransferase,Acetylase, Arylamine,Acetylases, Arylamine,Acetyltransferases, Arylamine,Arylamine N Acetyltransferase,Arylamine N-Acetyltransferase, Acetyl-CoA,N-Acetyltransferase, Acetyl-CoA Arylamine,N-Acetyltransferase, Arylamine
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D017698 Postmenopause The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life. Post-Menopause,Post-menopausal Period,Postmenopausal Period,Period, Post-menopausal,Period, Postmenopausal,Post Menopause,Post menopausal Period,Post-Menopauses

Related Publications

C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
February 1997, Pharmacogenetics,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
January 2004, Cancer detection and prevention,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
January 2001, Journal of applied genetics,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
January 2014, Harefuah,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
August 2007, American journal of epidemiology,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
February 1997, Pharmacogenetics,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
April 1997, Pharmacogenetics,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
May 1998, Clinical genetics,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
August 1998, Pharmacogenetics,
C B Ambrosone, and J L Freudenheim, and J R Marshall, and S Graham, and J E Vena, and J R Brasure, and A M Michalek, and R Laughlin, and T Nemoto, and P G Shields
December 1994, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!